Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Biology & Therapy|November 14, 2003
Targeting adult and pediatric cancers via cell-based vaccines and the prospect of activated B lymphocytes as a novel modalityChristina M Coughlin, Robert H Vonderheide
Chinese Clinical Oncology|December 9, 2014
Adaptive randomized phase II design for biomarker threshold selection and independent evaluationLindsay A Renfro, Christina M Coughlin, Axel M Grothey, et al.
Chinese Clinical Oncology|April 6, 2015
Adaptive randomized phase II design for biomarker threshold selection and independent evaluationLindsay A Renfro, Christina M Coughlin, Axel M Grothey, et al.
Breast Cancer Research and Treatment|August 31, 2010
Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapyChristina M Coughlin, Daniel S Johnston, Andrew Strahs, et al.
Biomarkers in Medicine|May 19, 2010
Opportunities posed by novel patient selection biomarker approaches in oncology drug development: going beyond the cytotoxicsGrant Sellar, John D Alvarez, Frank Loganzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumorsLuis A Diaz, Christina M Coughlin, Susan C Weil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivoGregor S D Reid, Xiaochuan Shan, Christina M Coughlin, et al.
Nature Clinical Practice. Oncology|November 3, 2006
Interferon beta adenoviral gene therapy in a patient with ovarian cancerDaniel H Sterman, Colin T Gillespie, Richard G Carroll, et al.
Pageof 2